A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a ...

Early initiation of tofersen (Qalsody) was associated with a numerically slower decline in people with SOD1 amyotrophic ...

MyoRegulator, a device to be used at home to slow disability progression in ALS, has been granted breakthrough device ...

Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that ...

NUZ-001, an investigational oral therapy for ALS, is officially the ninth compound to be included in the HEALEY ALS platform ...

This story is part of a series on the current progression in Regenerative Medicine. In 1999, I defined regenerative medicine as the collection of interventions that restore tissues and organs damaged ...

IV edaravone-treated patient had longer disease progression milestone-free time for all 6 milestones compared with control. Treatment with intravenous (IV) edaravone was associated with fewer reported ...

Amyotrophic lateral sclerosis (ALS) is probably one of the most devastating diagnoses that we should all hope to never hear. Also known as Lou Gehrig's disease, or motor neuron disease, ALS is a prog ...

Health Technology Assessment (HTA) evaluations issued by Canada's Drug Agency (CDA) and the Institut national d'excellence en santé et en services sociaux (INESSS) for QALSODY (TM) (tofersen injection ...

Earlier, he revealed he has been diagnosed with the condition that affects nerve cells in the brain and spinal cord ...

Actor Eric Dane has revealed he has been diagnosed with ALS, a progressive neurodegenerative disease that damages motor ...

A new drug may slow progression of — and even reverse — symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a new study published Monday finds. The drug, tofersen, targets a very ...